| 1 |
33431788 |
10.1038/s41392-020-00437-8 |
2022 |
CREBBP/EP300 mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-associated macrophage polarization via FBXW7-NOTCH-CCL2/CSF1 axis. |
KMT2C |
| 2 |
33829512 |
10.1111/his.14378 |
2022 |
Bcl-2-negative IGH-BCL2 translocation-negative follicular lymphoma of the thyroid differs genetically and epigenetically from Bcl-2-positive IGH-BCL2 translocation-positive follicular lymphoma. |
KMT2C |
| 3 |
34341476 |
10.1038/s10038-021-00965-3 |
2022 |
PAX3/7-FOXO1 fusion-negative alveolar rhabdomyosarcoma in Schuurs-Hoeijmakers syndrome. |
KMT2C |
| 4 |
34390161 |
10.1002/pbc.29285 |
2022 |
Molecular features of non-anaplastic peripheral T-cell lymphoma in children and adolescents. |
KMT2C |
| 5 |
34591292 |
10.1007/s12185-021-03229-0 |
2022 |
Successful treatment of hepatosplenic T-cell lymphoma with fludarabine, high-dose cytarabine and subsequent unrelated umbilical cord blood transplantation. |
KMT2C |
| 6 |
34980830 |
10.1097/PAS.0000000000001859 |
2022 |
Clinicopathologic and Genetic Features of Primary T-cell Lymphomas of the Central Nervous System: An Analysis of 11 Cases Using Targeted Gene Sequencing. |
KMT2C |
| 7 |
35008340 |
10.3390/cancers14010176 |
2022 |
Recent Advances in the Genetic of MALT Lymphomas. |
KMT2C |
| 8 |
35300216 |
10.2147/JIR.S341355 |
2022 |
The Mutation of <i>BTG2</i> Gene Predicts a Poor Outcome in Primary Testicular Diffuse Large B-Cell Lymphoma. |
KMT2C |
| 9 |
35504960 |
10.1038/s41598-022-11247-z |
2022 |
A retrospective study on the clinicopathological and molecular features of 22 cases of natural killer/T-cell lymphoma in children and adolescents. |
KMT2C |
| 10 |
35522148 |
10.3324/haematol.2021.280005 |
2022 |
Focal structural variants revealed by whole genome sequencing disrupt the histone demethylase <i>KDM4C</i> in B cell lymphomas. |
KMT2C |
| 11 |
35834399 |
10.1097/PAS.0000000000001932 |
2022 |
Pediatric-Type Indolent B-Cell Lymphomas With Overlapping Clinical, Pathologic, and Genetic Features. |
KMT2C |
| 12 |
31028364 |
10.1038/s41379-019-0279-8 |
2021 |
Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified. |
KMT2C |
| 13 |
32191807 |
10.1182/bloodadvances.2019001396 |
2021 |
Genomic profiles and clinical outcomes of de novo blastoid/pleomorphic MCL are distinct from those of transformed MCL. |
KMT2C |
| 14 |
32469082 |
10.1002/cncr.32866 |
2021 |
Genome-defined African ancestry is associated with distinct mutations and worse survival in patients with diffuse large B-cell lymphoma. |
KMT2C |
| 15 |
32560455 |
10.3390/cancers12061603 |
2021 |
A Novel JAK1 Mutant Breast Implant-Associated Anaplastic Large Cell Lymphoma Patient-Derived Xenograft Fostering Pre-Clinical Discoveries. |
KMT2C |
| 16 |
33655698 |
10.1002/cam4.3649 |
2021 |
Integration of comprehensive genomic profiling, tumor mutational burden, and PD-L1 expression to identify novel biomarkers of immunotherapy in non-small cell lung cancer. |
KMT2C |
| 17 |
34256839 |
10.1186/s40164-021-00232-3 |
2021 |
Progress in molecular feature of smoldering mantle cell lymphoma. |
KMT2C |
| 18 |
29629950 |
10.1097/PAI.0000000000000644 |
2020 |
A Survey of Somatic Mutations in 41 Genes in a Cohort of T-Cell Lymphomas Identifies Frequent Mutations in Genes Involved in Epigenetic Modification. |
KMT2C |
| 19 |
31092896 |
10.1038/s41375-019-0473-1 |
2020 |
Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling. |
KMT2C |
| 20 |
31221981 |
10.1038/s12276-019-0230-6 |
2020 |
The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism. |
KMT2C |
| 21 |
31288594 |
10.1080/10428194.2019.1630620 |
2020 |
Misidentification of <i>MLL3</i> and other mutations in cancer due to highly homologous genomic regions. |
KMT2C |
| 22 |
31774495 |
10.1182/blood.2019001904 |
2020 |
Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL. |
KMT2C |
| 23 |
32239765 |
10.1002/ajh.25796 |
2020 |
Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) - outcomes and mutation profile from venetoclax resistant MCL patients. |
KMT2C |
| 24 |
32770099 |
10.1038/s41598-020-70310-9 |
2020 |
Genetic heterogeneity and prognostic impact of recurrent ANK2 and TP53 mutations in mantle cell lymphoma: a multi-centre cohort study. |
KMT2C |
| 25 |
30401751 |
10.1182/bloodadvances.2018022962 |
2019 |
Insights into the genomic landscape of MYD88 wild-type Waldenström macroglobulinemia. |
KMT2C |
| 26 |
26647218 |
10.1158/1078-0432.CCR-15-2123 |
2018 |
Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas. |
KMT2C |
| 27 |
27203213 |
10.18632/oncotarget.9400 |
2018 |
Genetic landscape of T- and NK-cell post-transplant lymphoproliferative disorders. |
KMT2C |
| 28 |
26551667 |
10.1038/ng.3442 |
2016 |
The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome. |
KMT2C |
| 29 |
26880370 |
10.1186/s12943-016-0500-z |
2016 |
Mutation of epigenetic regulators TET2 and MLL3 in patients with HTLV-I-induced acute adult T-cell leukemia. |
KMT2C |
Datasets
Models
